Maxim Group analyst Matthew Galinko has maintained their bullish stance on NAKA stock, giving a Buy rating on November 20.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Matthew Galinko has given his Buy rating due to a combination of factors that highlight Kindly MD’s strategic positioning and potential for future growth. Despite a recent pullback in Bitcoin prices and negative sentiment in the digital asset market, the company holds a significant amount of Bitcoin, which provides a substantial asset base. The anticipated acquisition of BTC Inc. is expected to bring in meaningful revenue and positive cash flow, further strengthening the company’s financial position.
Additionally, the company has sufficient cash reserves and a loan agreement that supports its organic growth plans, although additional capital may be needed for further Bitcoin purchases or mergers and acquisitions. While Galinko has lowered the price target to $1.50 from $8.00 due to revised revenue estimates and a lower expected future Bitcoin price, the Buy rating is maintained based on a sum-of-the-parts analysis. This analysis considers the future value of Bitcoin holdings, market value of equity portfolio holdings, and net debt, indicating a favorable long-term outlook for Kindly MD.
In another report released on November 20, B. Riley Securities also maintained a Buy rating on the stock with a $1.00 price target.